The change in the circulating insulin-like growth factor binding protein 1 isoform pattern during the course of oral glucose tolerance test

Metabolism: Clinical and Experimental

Volumn 57, Issue 5, 2008, Pages 658-661

  Nedić, Olgica ^a   Masnikosa, Romana ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; GLUCOSE; INSULIN; PHOSPHATE; SOMATOMEDIN BINDING PROTEIN 1;

ADULT; ARTICLE; AUTORADIOGRAPHY; CLINICAL ARTICLE; CONTROLLED STUDY; DENATURATION; ELECTROPHORESIS; FEMALE; GLUCOSE INTAKE; GLUCOSE TOLERANCE TEST; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; TIME;

ADULT; FEMALE; GLUCOSE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; PHOSPHORYLATION; PROTEIN ISOFORMS;

EID: 42949135944     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2007.12.010     Document Type: Article

References (22)

1. Khosravi J., Krishna R.G., Bodani U., Diamandi A., Khaja N., Kalra B., and Kumar A. Immunoassay of serine-phosphorylated isoform of insulin-like growth factor (IGF) binding protein (IGFBP)-1. Clin Biochem 40 (2007) 86-93
2. Wolk K., Larsson S.C., Vessby B., Wolk A., and Brismar K. Metabolic, anthropometric, and nutritional factors as predictors of circulating insulin-like growth factor binding protein-1 levels in middle-aged and elderly men. J Clin Endocrinol Metab 89 (2004) 1879-1884
3. Iwashita M., Sakai K., Kudo Y., and Takeda Y. Phosphoisoforms of insulin-like growth factor binding protein-1 in appropriate-for-gestational-age and small-for-gestational-age fetuses. Growth Horm IGF Res 8 (1998) 487-493
4. 2-Macroglobulin: a new component in the insulin-like growth factor/insulin-like growth factor binding protein-1 axis. J Biol Chem 276 (2001) 41668-41674
5. Westwood M., Gibson J.M., Davies A.J., Young R.J., and White A. The phosphorylation pattern of insulin-like growth factor binding protein-1 in normal plasma is different from that in amniotic fluid and changes during pregnancy. J Clin Endocrinol Metab 79 (1994) 1735-1741
6. Crossey P.A., Jones J.S., and Miell J.P. Dysregulation of the insulin/IGF binding protein-1 axis in transgenic mice is associated with hyperinsulinemia and glucose intolerance. Diabetes 49 (2000) 457-465
7. Hossenlopp P., Seurin D., Segovia-Quinson B., Hardouin S., and Binoux M. Analysis of serum insulin-like growth factor binding proteins using Western blotting: use of the method for titration of the binding proteins and competitive binding studies. Anal Chem 154 (1986) 138-143
8. Baričević I., Jones D.R., Nikolić J.A., and Nedić O. Gastrointestinal inflammation and the circulating IGF system in humans. Horm Metab Res 38 (2006) 22-27
9. Nedić O., Miloradović J., Ratković M., and Masnikosa R. Insulin and C-peptide response in healthy persons and individuals with impaired glucose metabolism during oral glucose tolerance test. Jugoslov Med Biohem 24 (2005) 35-39
10. Garcia B.A., Shabanowitz J., and Hunt D.F. Analysis of protein phosphorylation by mass spectrometry. Methods 35 (2005) 256-264
11. Khosravi M.J., Diamandi A., and Mistry J. Immunoassay of insulin-like growth factor binding protein-1. Clin Chem 43 (1997) 523-532
12. Users manual for Active Total IGFBP-1 IRMA DSL-7800 (2003), DSL, Webster, USA
13. Gibson J.M., Aplin J.D., White A., and Westwood M. Regulation of IGF bioavailability in pregnancy. Mol Hum Reprod 7 (2001) 79-87
14. Murphy L.J. The role of the insulin-like growth factors and their binding proteins in glucose homeostasis. Exp Diabesity Res 4 (2003) 213-224
15. Frystyk J., Grøfte T., Skjærbæk C., and Ørskov H. The effect of oral glucose on serum free insulin-like growth factor-I and -II in healthy adults. J Clin Endocrinol Metab 82 (1997) 3124-3127
16. Chen J.W., Nielsen M.F., Caumo A., Vilstrup H., Christiansen J.S., and Frystyk J. Changes in bioactive IGF-I and IGF-binding protein-1 during an oral glucose tolerance test in patients with liver cirrhosis. Eur J Endocrinol 155 (2006) 285-292
17. Lewitt M.S., Hall K., Bang P., and Brismar K. Altered response of insulin-like growth factor binding protein 1 to nutritional deprivation in type 2 diabetes mellitus. Metab Clin Exp 54 (2005) 275-280
18. Lavoie J.M., Fillion Y., Couturier K., and Corriveau P. Selected contribution: evidence that the decrease in liver glycogen is associated with the exercise-induced increase in IGFBP-1. J Appl Physiol 93 (2002) 798-804
19. Motaghedi R., Gujral S., Sinha S., Sison C., Ten S., and Maclaren N.K. Insulin-like growth factor binding protein-1 to screen for insulin resistance in children. Diabetes Technol Ther 9 (2007) 43-51
20. Soriano-Guillén L., Barrios V., Campos-Barros Á., and Argente J. Ghrelin levels in obesity and anorexia nervosa: effect of weight reduction or recuperation?. J Pediatr 144 (2004) 36-42
21. Brismar K., Fernqvist-Forbes E., Wahren J., and Hall K. Effect of insulin on the hepatic production of insulin-like growth factor binding protein-1 (IGFBP-1), IGFBP-3, and IGF-I in insulin-dependent diabetes. J Clin Endocrinol Metab 79 (1994) 872-878
22. Zhang F., Sjöholm Å., and Zhang Q. Attenuation of insulin secretion by insulin-like growth factor binding protein-1 in pancreatic b-cells. Biochem Biophys Res Commun 362 (2007) 152-157